Amneal Pharmaceuticals Inc 's Revenue in the fiscal year 2025 $ 3,018.31 millions
Amneal Pharmaceuticals Inc 's Revenue in the fiscal year 2024 $ 2,793.44 millions
Amneal Pharmaceuticals Inc 's Revenue in the fiscal year 2023 $ 2,393.57 millions
Amneal Pharmaceuticals Inc 's Revenue in the fiscal year 2022 $ 2,200.71 millions
Amneal Pharmaceuticals Inc 's Revenue in the fiscal year 2021 $ 2,070.98 millions
AMRX Revenue third quarter 2026 Y/Y Growth Comment
Amneal Pharmaceuticals Inc reported Revenue increase of 10.04% year on year in the third quarter 2026, to $ 862.68 millions, this is lower than Amneal Pharmaceuticals Inc 's recent average Revenue increase of 16.07%.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 103 other companies have achieved higher Revenue growth. While Amneal Pharmaceuticals Inc ' s Revenue growth of 10.04% ranks overall at the positon no. 1732 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Amneal Pharmaceuticals Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
50.36 %
4.17 %
-21.05 %
(Jun 30 2018)
AMRX's III. Quarter Q/Q Revenue Comment
Amneal Pharmaceuticals Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 8.35%, to $ 862.68 millions, from $796.20 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 53 other companies have achieved higher Revenue quarter on quarter growth. While Amneal Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 801.
Amneal Pharmaceuticals Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 8.35%, to $ 862.68 millions, from $796.20 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 53 other companies have achieved higher Revenue quarter on quarter growth. While Amneal Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 801.
Amneal Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year
With the quarterly Revenue reported in the Sep 30 2026 period, Amneal Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 3,196 millions, company would post below average annual Revenue growth of 2.52% year on year, if the fiscal year would end at Sep 30 2026. A slow-down in the Amneal Pharmaceuticals Inc 's Revenue growth from the 796.2% growth in Jun 30 2026.
In the Healthcare sector 254 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 533 to 1509.
With the quarterly Revenue reported in the Sep 30 2026 period, Amneal Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 3,196 millions, company would post below average annual Revenue growth of -22.6% year on year, if the fiscal year would end at Sep 30 2026. A slow-down in the Amneal Pharmaceuticals Inc 's Revenue growth from the 796.2% growth in Jun 30 2026.
In the Healthcare sector 254 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 533 to 1509.
About Amneal Pharmaceuticals Inc Revenue Growth Rates (AMRX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
17.51%